On April 13, the U.S. Food and Drug Administration announced that seven metered-dose inhalers used for asthma and chronic obstructive pulmonary disease will gradually be removed from the market because they contain ozone-depleting cholorofluorocarbons (CFCs). Find more details and the schedule for removal at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm208302.htm.
© 2020 HealthCom Media
All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder